These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10507054)

  • 1. Senescence-accelerated mouse.
    Higuchi K; Hosokawa M; Takeda T
    Methods Enzymol; 1999; 309():674-86. PubMed ID: 10507054
    [No Abstract]   [Full Text] [Related]  

  • 2. Accelerated senile amyloidosis induced by amyloidogenic Apoa-II gene shortens the life span of mice but does not accelerate the rate of senescence.
    Higuchi K; Wang J; Kitagawa K; Matsushita T; Kogishi K; Naiki H; Kitado H; Hosokawa M
    J Gerontol A Biol Sci Med Sci; 1996 Jul; 51(4):B295-302. PubMed ID: 8680995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A-II gene and development of amyloidosis and senescence in a congenic strain of mice carrying amyloidogenic ApoA-II.
    Higuchi K; Naiki H; Kitagawa K; Kitado H; Kogishi K; Matsushita T; Takeda T
    Lab Invest; 1995 Jan; 72(1):75-82. PubMed ID: 7837794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic characterization of senescence-accelerated mouse (SAM).
    Higuchi K
    Exp Gerontol; 1997; 32(1-2):129-38. PubMed ID: 9088910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senescence-accelerated mouse (SAM): a novel murine model of accelerated senescence.
    Takeda T; Hosokawa M; Higuchi K
    J Am Geriatr Soc; 1991 Sep; 39(9):911-9. PubMed ID: 1885867
    [No Abstract]   [Full Text] [Related]  

  • 6. Age-associated decreases in the messenger ribonucleic acid level and the rate of synthesis of apolipoprotein A-II in murine senile amyloidosis.
    Kitagawa K; Naiki H; Takeda T; Higuchi K
    Lab Invest; 1994 Apr; 70(4):565-71. PubMed ID: 8176896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice. Relationship between the molecular type of apoA-II and mouse senile amyloidosis.
    Higuchi K; Kitagawa K; Naiki H; Hanada K; Hosokawa M; Takeda T
    Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):427-33. PubMed ID: 1683229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wild type ApoA-II gene does not rescue senescence-accelerated mouse (SAMP1) from short life span and accelerated mortality.
    Wang J; Matsushita T; Kogishi K; Xia C; Ohta A; Chiba T; Nakamura A; Kondo H; Mori M; Hosokawa M; Higuchi K
    J Gerontol A Biol Sci Med Sci; 2000 Sep; 55(9):B432-9. PubMed ID: 10995040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of murine senile amyloidosis.
    Naiki H; Higuchi K; Shimada A; Takeda T; Nakakuki K
    Lab Invest; 1993 Mar; 68(3):332-7. PubMed ID: 8095565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced coenzyme Q10 supplementation decelerates senescence in SAMP1 mice.
    Yan J; Fujii K; Yao J; Kishida H; Hosoe K; Sawashita J; Takeda T; Mori M; Higuchi K
    Exp Gerontol; 2006 Feb; 41(2):130-40. PubMed ID: 16387461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse senile amyloidosis. ASSAM amyloidosis in mice presents universally as a systemic age-associated amyloidosis.
    Higuchi K; Naiki H; Kitagawa K; Hosokawa M; Takeda T
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(4):231-8. PubMed ID: 1681611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrahepatic expression of apolipoprotein A-II in mouse tissues: possible contribution to mouse senile amyloidosis.
    Fu L; Matsuyama I; Chiba T; Xing Y; Korenaga T; Guo Z; Fu X; Nakayama J; Mori M; Higuchi K
    J Histochem Cytochem; 2001 Jun; 49(6):739-48. PubMed ID: 11373320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p63 deficiency activates a program of cellular senescence and leads to accelerated aging.
    Keyes WM; Wu Y; Vogel H; Guo X; Lowe SW; Mills AA
    Genes Dev; 2005 Sep; 19(17):1986-99. PubMed ID: 16107615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique mutations in mitochondrial DNA of senescence-accelerated mouse (SAM) strains.
    Mizutani J; Chiba T; Tanaka M; Higuchi K; Mori M
    J Hered; 2001; 92(4):352-5. PubMed ID: 11535650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dietary unsaturated fatty acids on senile amyloidosis in senescence-accelerated mice.
    Umezawa M; Higuchi K; Mori M; Matushita T; Hosokawa M
    J Gerontol A Biol Sci Med Sci; 2009 Jun; 64(6):646-52. PubMed ID: 19377016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of senile amyloid precursor and amyloidogenesis. Age-related acceleration of apolipoprotein A-II clearance in the senescence accelerated mouse.
    Naiki H; Higuchi K; Yonezu T; Hosokawa M; Takeda T
    Am J Pathol; 1988 Mar; 130(3):579-87. PubMed ID: 3126661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging the aging-disease dichotomy. I. The amyloidosis model.
    Blumenthal HT; Premachandra BN
    Perspect Biol Med; 1990; 33(3):402-20. PubMed ID: 2188213
    [No Abstract]   [Full Text] [Related]  

  • 18. Amyloidosis: a universal disease of aging?
    Blumenthal HT
    J Gerontol A Biol Sci Med Sci; 2004 Apr; 59(4):361-9. PubMed ID: 15071080
    [No Abstract]   [Full Text] [Related]  

  • 19. Accelerated accumulation of somatic mutations in the senescence-accelerated mouse.
    Odagiri Y; Uchida H; Hosokawa M; Takemoto K; Morley AA; Takeda T
    Nat Genet; 1998 Jun; 19(2):116-7. PubMed ID: 9620763
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased expression of hippocampal cholinergic neurostimulating peptide-related components and their messenger RNAs in the hippocampus of aged senescence-accelerated mice.
    Matsukawa N; Tooyama I; Kimura H; Yamamoto T; Tsugu Y; Oomura Y; Ojika K
    Neuroscience; 1999 Jan; 88(1):79-92. PubMed ID: 10051191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.